Patent holdings for IPC class C07D 221/04

Total number of patents in this class: 253

10-year publication summary

35
24
14
16
17
7
24
18
15
5
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Tetra Discovery Partners, LLC
12
8
Glaxo Group Limited
4496
6
Genentech, Inc.
3742
6
SHY Therapeutics LLC
24
6
Bristol-myers Squibb Company
5080
5
Hoffmann-La Roche Inc.
3060
5
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
762
5
Enanta Pharmaceuticals, Inc.
420
4
Givaudan SA
1760
4
InterMune, Inc.
97
4
Jiangsu Hengrui Medicine Co., Ltd.
780
4
Nippon Soda Co., Ltd.
890
4
Shanghai Hengrui Pharmaceutical Co., Ltd.
588
4
Novartis AG
11238
3
F. Hoffmann-La Roche AG
7958
3
Bayer AG
3045
3
Bayer Pharma AG
1096
3
Vertex Pharmaceuticals Incorporated
1581
3
Arbutus Biopharma Corporation
183
3
Katholieke Universiteit Leuven K.u. Leuven R & D
217
3
Other owners 167